Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Medical Instruments & Suppliesβ
2026-04-08NNNN3Anbio Biotechnology Director Cany Xu Form 3 Filing - No Securities Owned
This is a Form 3 filing by Cany Xu, a director of Anbio Biotechnology (ticker: NNNN), reporting no securities ownership as of March 18, 2026. The filing indicates that Xu is a director of the company but does not own any securities. The filing was signed on April 8, 2026, and reports the ownership status as of the peri...
Small CapMedical Instruments & Supplies
2026-04-08NNNN3Chris Tian Form 3 Filing for Anbio Biotechnology
This is a Form 3 filing by Chris Tian, the Chief Business Officer (CBO) of Anbio Biotechnology (ticker: NNNN). The filing reports that as of March 18, 2026, Chris Tian owns no securities in the company. The filing was signed on April 8, 2026, and indicates that Chris Tian is an officer of the company (CBO) but not a di...
Small CapMedical Instruments & Supplies
2026-04-08NNNN3Michael Lau's Form 3 Filing as CEO of Anbio BiotechnologyMEDIUM
This is a Form 3 filing by Michael Lau, who has been appointed as CEO of Anbio Biotechnology (ticker: NNNN). The filing represents an initial statement of beneficial ownership of securities, indicating that Mr. Lau has no securities owned as of the reporting date of March 18, 2026. The filing was signed on April 8, 202...
Small CapMedical Instruments & Supplies
2026-04-08NNNN3Form 3 Filing for Anbio Biotechnology: Ownership Change
This filing is a Form 3, which reports initial beneficial ownership of securities. Nancy Hartzler, identified as a director of Anbio Biotechnology, has reported her ownership. The filing indicates that Ms. Hartzler does not own any securities as of the reporting date, March 18, 2026. The signature date is April 8, 2026...
Small CapMedical Instruments & Supplies
2026-04-08NNNN3Suki Song's Form 3 Filing as CFO of Anbio Biotechnology
This is a Form 3 filing by Suki Song, who is reporting her initial statement of beneficial ownership of securities in Anbio Biotechnology (ticker: NNNN). The filing indicates that Song holds the position of Chief Financial Officer (CFO) at the company. The filing was signed on April 8, 2026, with a reporting period end...
Small CapMedical Instruments & Supplies